Nyrada Inc.

Healthcare

The U.S registered Nyrada Inc. (ASX:NYR) is a preclinical stage, drug development company that prominently focusses on advancing the non-oncology asset development. Founded in 2017, Nyrada got listed on Australian Securities Exchange on 16 January 2020. The biotechnology company specialises in novel small molecule drug development targeted for cardiovascular, neurodegenerative and chronic inflammatory diseases.

Similar Companies

Load More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK